Published On: Mon, Mar 20th, 2017

ZS Pharma, Inc. (ZSPH) – Latest Broker Consensus

Below are the most recently updated broker updates which include ratings and price targets for ZS Pharma, Inc. (ZSPH).

11/18/2015 – Broker: Citigroup Rating: neutral New Target: 82 downgrade

11/09/2015 – Broker: JP Morgan Rating: neutral New Target: 90 downgrade

11/09/2015 – Broker: Morgan Stanley Rating: equal weight New Target: 90 downgrade

11/09/2015 – Broker: Credit Suisse Rating: neutral New Target: 90 downgrade

11/06/2015 – Broker: William Blair Rating: market perform downgrade

09/11/2015 – Broker: BMO Capital Markets Rating: outperform New Target: 83 reiteration

The average price target from the most recent broker reports is 87.00

The stock increased +0.00% (+0.00) during the last days session, reaching 89.98 and roughly 0 shares were bought or sold by traders.